Deputy manager of the firm’s private equity practice, Barbara J. Shander advises private equity funds and their portfolio companies on structuring and negotiating complex business transactions including mergers and acquisitions, dispositions, equity financings, joint ventures, commercial agreements, incentive equity and other compensation plans, leveraged dividends, corporate governance, and general corporate matters. Barb represents buyers and sellers in transactions involving privately held businesses, and subsidiaries and divisions of public companies, and has experience in roll-up, corporate carve-out and distressed transactions. She represents numerous private equity funds, ranging from lower middle-market funds to mutlibillion dollar funds.
In addition to advising institutional investors on portfolio investments and buy-out transactions, she serves as outside general counsel to numerous companies, and advises them on a variety of legal matters. Barb has experience in the use of representations and warranties insurance, and regularly uses this product in transactions representing both buyers and sellers. She has led numerous transactions of varying sizes in several sectors including healthcare, financial services, energy, utilities, retail, technology, telecommunications, and manufacturing. Barb is a prior board member of the Philadelphia chapter of the Association for Corporate Growth (ACG) and remains an active member of the chapter.
Represented Exelon Corporation in the sale of its interests in the Conemaugh and Keystone power plants to Arclight Capital Partners LLC.
Represented WIRB-Copernicus Group, a portfolio company of Arsenal Capital Partners, in its acquisitions of ePharmaSolutions, New England Independent Review Board and IRBNet.
Represented Creative Co-Op, a portfolio company of Eureka Growth Capital, in its acquisition of Bloomingville, a leading European designer and distributor of home lifestyle products.
Represented TractManager, Inc., a portfolio company of Arsenal Capital Partners, in its acquisition of MD Buyline.
Represented InnoPharma Inc. in its sale to Pfizer Inc.
Represented Sun Capital Partners in the sale of its affiliate, Cornerstone Research & Development Company, to Integrity Nutraceuticals, an affiliate of H.I.G. Capital.
Represented Acurian in its sale to Pharmaceutical Product Development LLC.
Represented Harry’s Fresh Foods, a portfolio company of Sun Capital Partners, in its sale to JGC Foods LLC, the food-focused subsidiary of Seattle-based Joshua Green Corporation.
Represented Dahlman Rose & Company, a research-driven privately held New York investment bank, in its sale to Cowen Group Inc.
Represented Eureka Growth Capital in the recapitalization, in partnership with management, of Creative Co-Op Inc. and affiliated companies.
Represented Exelon Corporation in the sale of three Maryland coal-fired power plants to Raven Power Holdings LLC, a new portfolio company of Riverstone Holdings LLC.
Represented Arsenal Capital Partners in its acquisitions of Western Institutional Review Board and Copernicus Group Institutional Review Board.
Represented Sun Capital Partners in its sale of Raybestos Powertrain to Monomoy Capital Partners.
Represented Galen Partners in its growth equity financing of Sharecare and HCPlexus, Inc., a portfolio company of Galen Partners, in its acquisition by Sharecare.
Represented NetBoss Technologies, a portfolio company of Eureka Growth Capital, in its acquisition of Sidonis Technologies, an emerging leader in service assurance.
Villanova University School of Law, 1995, J.D.
University of Delaware, 1992, B.S.
Awards and Affiliations
Recommended, M&A/Corporate and Commercial - Private Equity Buyouts, The Legal 500 US (2011–2018)
Best of the Bar, Corporate, Philadelphia Business Journal (2018)
Former Board Member, Philadelphia Chapter of the Association for Corporate Growth
Former Board Member, The Wellness Community of Philadelphia